Short pages

Jump to navigation Jump to search

Showing below up to 50 results in range #11,471 to #11,520.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. (hist) Abnormal posturing CT [295 bytes]
  2. (hist) Abnormal posturing other imaging findings [295 bytes]
  3. (hist) Abnormal posturing cost-effectiveness of therapy [295 bytes]
  4. (hist) Nausea and vomiting ultrasound [295 bytes]
  5. (hist) Cluster headache cost-effectiveness of therapy [295 bytes]
  6. (hist) Cluster headache future or investigational therapies [295 bytes]
  7. (hist) Blepharitis cost-effectiveness of therapy [295 bytes]
  8. (hist) Interface not showing all answers [295 bytes]
  9. (hist) Ophthalmoparesis case study one [295 bytes]
  10. (hist) Blepharitis MRI [295 bytes]
  11. (hist) Hemorrhoids ultrasound [295 bytes]
  12. (hist) Drug induced liver injury other imaging findings [295 bytes]
  13. (hist) Membranous glomerulonephritis electrocardiogram [295 bytes]
  14. (hist) Epidural hematoma other imaging findings [295 bytes]
  15. (hist) Mast cell tumor secondary prevention [295 bytes]
  16. (hist) Cowden syndrome primary prevention [295 bytes]
  17. (hist) Amnesia surgery [295 bytes]
  18. (hist) Epicranium [296 bytes]
  19. (hist) Diplosome [296 bytes]
  20. (hist) Ichthyolith [296 bytes]
  21. (hist) Pyeloplasty [296 bytes]
  22. (hist) Jeff Moy [296 bytes]
  23. (hist) Microvessel [296 bytes]
  24. (hist) Co-amoxiclav contraindications [296 bytes]
  25. (hist) Cervical cancer other imaging findings [296 bytes]
  26. (hist) Cycasin [296 bytes]
  27. (hist) Obesity CT [296 bytes]
  28. (hist) Hyperthyroidism future or investigational therapies [296 bytes]
  29. (hist) Splenomegaly risk factors [296 bytes]
  30. (hist) Adrenoleukodystrophy x ray [296 bytes]
  31. (hist) Aggressive NK-cell leukemia historical perspective [296 bytes]
  32. (hist) Aggressive NK-cell leukemia classification [296 bytes]
  33. (hist) Aggressive NK-cell leukemia causes [296 bytes]
  34. (hist) Aggressive NK-cell leukemia differential diagnosis [296 bytes]
  35. (hist) Aggressive NK-cell leukemia risk factors [296 bytes]
  36. (hist) Aggressive NK-cell leukemia natural history, complications and prognosis [296 bytes]
  37. (hist) Aggressive NK-cell leukemia physical examination [296 bytes]
  38. (hist) Aggressive NK-cell leukemia CT [296 bytes]
  39. (hist) Aggressive NK-cell leukemia other imaging findings [296 bytes]
  40. (hist) Aggressive NK-cell leukemia medical therapy [296 bytes]
  41. (hist) Aggressive NK-cell leukemia surgery [296 bytes]
  42. (hist) Aggressive NK-cell leukemia primary prevention [296 bytes]
  43. (hist) Aggressive NK-cell leukemia secondary prevention [296 bytes]
  44. (hist) Aggressive NK-cell leukemia cost-effectiveness of therapy [296 bytes]
  45. (hist) Aggressive NK-cell leukemia future or investigational therapies [296 bytes]
  46. (hist) Aggressive NK-cell leukemia case study one [296 bytes]
  47. (hist) Diabetic neuropathy secondary prevention [296 bytes]
  48. (hist) Diabetes insipidus pituitary hormone testing [296 bytes]
  49. (hist) Diabetes insipidus water deprivation test [296 bytes]
  50. (hist) Rheumatoid pleuritis medical therapy [296 bytes]

View ( | ) (20 | 50 | 100 | 250 | 500)